This reply
Asdfgh mark this message contains true information
originally written by Asdfgh
博瑞生物医药(苏州)股份有限公司確實於2020/2/12於上海證交所公告仿製訊息,但因面對美國吉利德公司擁有藥物應用的專利,博瑞生物醫藥回應,將藥物投入市場需要吉利德的授權,這一過程將會「存在重大不確定性」。

References

http://static.sse.com.cn//disclosure/listedinfo/bulletin/star/c/688166_20200212_1.pdf
http://www.sse.com.cn/assortment/stock/list/info/announcement/index.shtml?productId=688166
https://www.nownews.com/news/20200212/3931303/

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.